Difference between revisions of "Fibrocystic breast changes"
Jump to navigation
Jump to search
m (→Microscopic examination: -fibrocystic) |
m (<noinclude>) |
||
(One intermediate revision by the same user not shown) | |||
Line 14: | Line 14: | ||
===Differential diagnosis=== | ===Differential diagnosis=== | ||
− | Sclerosing adenosis may look similar to [[invasive ductal carcinoma]] (IDC), but IDC will:<ref name=PathologyOutlines/> | + | Sclerosing adenosis may look similar to [[invasive ductal carcinoma]] (IDC), but IDC will:<ref name=PathologyOutlines-fibrocystic/> |
*Not be lobular at low power | *Not be lobular at low power | ||
*Have marked cellular atypia | *Have marked cellular atypia | ||
Line 21: | Line 21: | ||
When unsure, perform immunohistochemistry for myoepithelial markers (preferably '''p63''' and '''calponin''' in breast lesions): | When unsure, perform immunohistochemistry for myoepithelial markers (preferably '''p63''' and '''calponin''' in breast lesions): | ||
[[File:Chromogenic immunohistochemistry for calponin in sclerosing adenosis.jpg|thumb|center|Immunostain with a myoepithelial marker (calponin) in sclerosing adenosis, showing myoepithelial cells surrounding the ducts, thereby excluding invasive carcinoma.]] | [[File:Chromogenic immunohistochemistry for calponin in sclerosing adenosis.jpg|thumb|center|Immunostain with a myoepithelial marker (calponin) in sclerosing adenosis, showing myoepithelial cells surrounding the ducts, thereby excluding invasive carcinoma.]] | ||
− | + | <noinclude> | |
{{Bottom}} | {{Bottom}} | ||
+ | </noinclude> |
Revision as of 10:50, 4 December 2022
Author:
Mikael Häggström [note 1]
Contents
Presentations
Microscopic examination
Types:
Sclerosing adenosis, with an increase in glandular elements in addition to stromal proliferation that distorts and compresses glands.[1]
Differential diagnosis
Sclerosing adenosis may look similar to invasive ductal carcinoma (IDC), but IDC will:[1]
- Not be lobular at low power
- Have marked cellular atypia
- Have no myoepithelial cells surrounding ducts.
When unsure, perform immunohistochemistry for myoepithelial markers (preferably p63 and calponin in breast lesions):
Notes
- ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.
Main page
References
- ↑ 1.0 1.1 Jaya Ruth Asirvatham, M.B.B.S., Julie M. Jorns, M.D.. Breast - Fibrocystic changes - Sclerosing adenosis. Pathology Outlines. Topic Completed: 1 January 2015. Minor changes: 31 December 2020
Image sources